Profile data is unavailable for this security.
About the company
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
- Revenue in HKD (TTM)3.45bn
- Net income in HKD-1.62bn
- Incorporated2013
- Employees1.87k
- LocationZai Lab LtdBuilding B, 899 Halei Road, PudongSHANGHAI 201203ChinaCHN
- Phone+86 2 161632588
- Fax+86 2 161632570
- Websitehttps://www.zailaboratory.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hbm Holdings Ltd | 904.32m | 571.07m | 10.28bn | 210.00 | 15.96 | 4.25 | 17.19 | 11.37 | 0.7405 | 0.7405 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,796,901.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.63bn | -299.61m | 10.32bn | 15.58k | -- | 0.4408 | 11.36 | 0.5854 | -0.0595 | -0.0595 | 3.50 | 4.65 | 0.4326 | 1.59 | 1.71 | 1,052,615.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Luye Pharma Group Ltd | 6.98bn | 449.06m | 10.79bn | 5.12k | 22.62 | 0.611 | 6.74 | 1.55 | 0.1194 | 0.1194 | 1.86 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,354,931.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.92bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
| Guangzhou Innogen Pharmaceutl Grp Co Ltd | -100.00bn | -100.00bn | 12.79bn | 105.00 | -- | 15.05 | -- | -- | -- | -- | -- | 1.84 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.39 | -- | 0.0769 | -- | -- | -- | 76.18 | -- | -- | -- |
| Everest Medicines Ltd | 963.07m | -745.25m | 13.88bn | 722.00 | -- | 2.90 | -- | 14.41 | -2.31 | -2.31 | 2.98 | 13.55 | 0.1684 | 13.97 | 3.04 | 1,448,222.00 | -13.03 | -29.28 | -14.21 | -31.67 | 69.92 | -- | -77.38 | -1,040.86 | 5.43 | -- | 0.1577 | -- | 461.16 | -- | -23.32 | -- | 16.96 | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.37bn | -91.22m | 15.00bn | 2.77k | -- | 3.04 | -- | 6.32 | -0.0098 | -0.0098 | 0.2572 | 0.5396 | 0.1894 | 1.49 | 3.86 | 889,784.80 | -3.05 | -3.60 | -5.01 | -5.05 | 66.29 | 73.13 | -16.08 | -19.74 | 1.61 | -1.36 | 0.1606 | -- | 2.18 | -7.96 | -301.10 | -- | -20.58 | 3.60 |
| CF PharmTech Inc | 683.23m | 31.40m | 15.03bn | 574.00 | 478.90 | 13.86 | 146.46 | 21.99 | 0.0762 | 0.0762 | 1.66 | 2.63 | -- | -- | -- | -- | -- | -- | -- | -- | 80.18 | -- | 4.60 | -- | 1.89 | -- | 0.076 | -- | 9.23 | -- | -33.53 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 3.70bn | 1.14bn | 16.29bn | 3.07k | 14.56 | 3.35 | 13.38 | 4.41 | 1.33 | 1.33 | 4.31 | 5.77 | 0.5642 | 2.35 | 12.33 | 1,168,238.00 | 17.60 | 14.71 | 24.67 | 22.82 | 76.62 | 75.04 | 31.20 | 29.56 | 3.32 | -- | 0.0517 | 40.93 | 14.56 | 11.42 | 16.05 | 62.72 | -9.54 | 25.83 |
| Zai Lab Ltd | 3.45bn | -1.62bn | 17.10bn | 1.87k | -- | 2.82 | -- | 4.96 | -1.52 | -1.52 | 3.21 | 5.37 | 0.4119 | 3.19 | 6.53 | -- | -19.29 | -33.80 | -27.61 | -39.12 | 61.52 | 64.07 | -46.83 | -186.77 | 2.68 | -- | 0.2108 | -- | 49.59 | 98.38 | 23.17 | -- | 32.19 | -- |
| Ascletis Pharma Inc | 2.67m | -292.52m | 17.61bn | 208.00 | -- | 7.57 | -- | 6,586.39 | -0.299 | -0.299 | 0.0027 | 2.19 | 0.0011 | 0.2668 | 11.59 | 11,577.58 | -12.10 | -8.46 | -12.73 | -8.80 | 36.21 | 7.91 | -10,937.78 | -522.12 | 14.53 | -- | 0.0023 | -- | -97.73 | -62.52 | -107.95 | -- | -40.26 | -- |
| Vigonvita Life Sciences Co Ltd | -100.00bn | -100.00bn | 20.11bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -94.07 | -- | -1,848.73 | -- | -- | -- |
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.31bn | 1.78k | 5.57 | 2.11 | 5.42 | 4.32 | 4.18 | 4.18 | 5.39 | 11.01 | 0.3966 | 7.09 | 3.86 | 2,598,691.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Ab&B Bio Tech Co Ltd JS | 366.27m | -253.90m | 22.39bn | 583.00 | -- | 587.93 | -- | 61.12 | -0.6453 | -0.6453 | 0.9309 | 0.0968 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to Zai Lab Ltd's reporting currency: Hong Kong Dollar HKD
21.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Wellington Management Co. LLPas of 31 Dec 2025 | 48.11m | 4.30% |
| Goldman Sachs International (Invt Mgmt)as of 18 Sep 2025 | 47.96m | 4.28% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 39.45m | 3.52% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 22.47m | 2.01% |
| Fidelity Management & Research Co. LLCas of 29 Oct 2025 | 21.25m | 1.90% |
| Fidelity Management & Research (Hong Kong) Ltd.as of 29 Oct 2025 | 18.51m | 1.65% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 14.80m | 1.32% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 10.93m | 0.98% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 10.47m | 0.94% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 8.54m | 0.76% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
